Dr. Indira Natarajan, a consultant stroke physician, highlights the burden of VTE on stroke aftercare and offers an insight into a pilot study evaluating the use of neuromuscular electrostimulation on the hospital’s stroke unit.
Dr. Indira Natarajan, a consultant stroke physician for the Royal Stoke University Hospital’s acute stroke team, highlights the burden of VTE on stroke aftercare and offers an insight into a pilot study evaluating the use of neuromuscular electrostimulation on the hospital’s stroke unit. In this article, he shares his experience of taking forward change to clinical practice.
A number of immobile patients who suffer ischaemic or haemorrhagic strokes are unable to tolerate intermittent pneumatic compression (IPC) to prevent venous thromboembolism (VTE). Recognising this issue, the stroke unit at Royal Stoke initiated an observational pilot study to assess a new neuromuscular electrostimulation technology to address this unmet need.
Through close collaboration with the developer of the device, Sky Medical Technology, a change to clinical practice has been pioneered to the benefit of patients and the stroke team. This work is now driving adoption of the device and change to clinical practice in other stroke centres across the UK and overseas.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
